Please assess the completion status of the following clinical trial:

Trial Title: Outcomes Study of Hyperinsulinemic Glucose Control in Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-90 years old~* Scheduled for cardiac surgery requiring cardiopulmonary bypass~Exclusion Criteria:~* Off-pump surgical procedures~* Anticipated deep hypothermic circulatory arrest~* In available, baseline cardiac troponin I (\>0.5 ng/L) or troponin T (\> 0.1 ng/mL) levels (at RVH or CC, respectively)~* Any contraindications to the proposed interventions~* Active infection, including patients with endocarditis or infected pacemaker leads.~* Any infection requiring long- term antibiotics ( \> 14 days)~* kidney disease requiring renal replacement therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- Hyperinsulinemic-normoglycemic clamp (Type: EXPERIMENTAL): Patients will be randomized to receive the hyperinsulinemic-normoglycemic clamp titrating the blood glucose to 80-110 mg/dL.
- Insulin at the standard of care levels (Type: OTHER): Group B will be administered insulin at the standard of care levels established by the participating institution.

Based on this trial design, predict the completion outcome and termination type (if applicable).